| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/06/1993 | CA1315678C Alpha-tocopherol based vesicles |
| 04/05/1993 | CA2079642A1 Medicament |
| 04/02/1993 | CA2079420A1 Pharmaceutical composition containing felbinac |
| 04/01/1993 | WO1993005795A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds |
| 04/01/1993 | WO1992018610A3 Compositions and methods for endothelial binding |
| 03/31/1993 | EP0534878A1 Recombinant DNA molecules containing the coding part of a VBeta17 chain of the T cell antigen receptor and uses thereof |
| 03/31/1993 | EP0534343A1 Substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo(b) thiophenes and 1,2-benzisothiazoles, a process for their preparation and their use as medicaments |
| 03/31/1993 | EP0533827A1 Novel oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same. |
| 03/31/1993 | EP0533703A1 Steroids which inhibit angiogenesis |
| 03/31/1993 | CN1070404A Heterocyclic derivatives |
| 03/30/1993 | US5198567 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them |
| 03/30/1993 | CA1315279C Anti-inflammatory agents |
| 03/30/1993 | CA1315202C Oral sustained release acetaminophen formulation and process |
| 03/27/1993 | CA2079197A1 Recombinant nda new molecules containing the codifying part of a vbeta 17 chain for the t-cells antigene receptor, preparat ion process, antibodies and drugs containing them |
| 03/25/1993 | CA2078810A1 Leukotriene biosynthesis inhibitors |
| 03/24/1993 | EP0533573A2 Derivatives of 3-cyclo alkyl-propen-2-amide, their tautomeres and salts and their use as antiinflammatory agents |
| 03/24/1993 | EP0533226A2 Novel chromophore containing compounds |
| 03/24/1993 | EP0533213A1 Use of azelastin and glycerine ethers for the treatment of psoriasis |
| 03/24/1993 | EP0533210A1 Protein C containing pharmaceutical preparations |
| 03/24/1993 | EP0533209A1 beta-sympathomimetic Protein C containing pharmaceutical preparation |
| 03/24/1993 | EP0532862A1 Use of rapamycin for the preparation of a medicament for the treatment of ocular inflammation |
| 03/24/1993 | EP0532634A1 Phthalamic acids and their isomers for treating leukotriene-related diseases |
| 03/24/1993 | EP0532621A1 Amide linked pyridyle-benzoic acid derivatives for treating leukotriene-related diseases |
| 03/24/1993 | EP0532550A1 Benzoic acid derivatives for treating leukotriene-related diseases |
| 03/24/1993 | EP0532531A1 Phenol and pyridinol derivatives as pharmaceuticals |
| 03/24/1993 | EP0353273B1 An anti-inflammatory oxidizing agent, the procedure for its production and various applications |
| 03/23/1993 | US5196404 Inhibitors of thrombin |
| 03/23/1993 | US5196402 S-adenosyl-methionine in the treatment of pancreatitis and of the immuno rejection in the pancreas transplant |
| 03/23/1993 | CA1314891C Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid like activity |
| 03/23/1993 | CA1314889C Glycerol derivatives, their preparation and their therapeutic use |
| 03/23/1993 | CA1314883C Enol ethers of 6-chloro-4-hydroxy-2-methyl-n-(2- pyridyl)-2h-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, a process for their preparation and their use |
| 03/18/1993 | WO1993005166A1 Methods for the selection, separation and fusion of cells |
| 03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
| 03/18/1993 | WO1993005070A1 Peptide inhibitors of inflammation mediated by selectins |
| 03/18/1993 | WO1993005034A1 Bicyclic sulphones, process for producing the same and medicaments containing the same |
| 03/18/1993 | WO1993005031A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
| 03/18/1993 | WO1993005014A1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them |
| 03/18/1993 | WO1993004700A1 Vα12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
| 03/18/1993 | WO1993004695A1 T cell receptor-based therapy for rheumatoid arthritis |
| 03/18/1993 | WO1993004692A1 Morphogen-induced modulation of inflammatory response |
| 03/18/1993 | WO1993004680A1 Macrocyclic immunomodulators |
| 03/18/1993 | WO1993004676A1 High content ibuprofen agglomerates and process to prepare them |
| 03/18/1993 | WO1993004675A1 Composition comprising a tramadol material and acetaminophen and its use |
| 03/18/1993 | CA2118695A1 Peptide inhibitors of inflammation mediated by selectins |
| 03/18/1993 | CA2117070A1 Methods for the selection, separation and fusion of cells |
| 03/18/1993 | CA2116526A1 T cell receptor-based therapy for rheumatoid arthritis |
| 03/18/1993 | CA2116339A1 V.alpha.12.1 t-cell receptor-specific reagents for diagnosing and treating rheumatoid arthritis |
| 03/18/1993 | CA2116229A1 Bicyclic sulfones, processes for their production and pharmaceutical agents containing them |
| 03/17/1993 | EP0532456A1 1-Acylpiperidine derivatives and their use as substance P antagonists |
| 03/17/1993 | EP0532239A1 Benzenesulphonamide derivatives as 5-lipoxygenase inhibitors |
| 03/17/1993 | EP0532027A1 Cyclic nitrones, their preparation and pharmaceutical compositions containing them |
| 03/17/1993 | EP0531901A2 Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity |
| 03/17/1993 | EP0531883A1 Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them |
| 03/17/1993 | EP0531823A1 Bicyclic carboxylic acid derivatives as anti-inflammatory agents |
| 03/17/1993 | EP0531598A1 1,4-Dihydropyridines with paf-antagonistic activity |
| 03/17/1993 | EP0531461A1 Biologically active peptides containing d-2-alkyltryptophan. |
| 03/17/1993 | EP0531443A1 Methods for treating inflammation and compounds and compositions suitable for use therein |
| 03/17/1993 | EP0531382A1 N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders |
| 03/17/1993 | CN1020103C 2,3,4,5,6,7-hexahydro-2,7-methylene-1,5-benzoxazonin and 1,4-benzoxazonin |
| 03/17/1993 | CN1020095C Process for dichloroaniline derivatives |
| 03/16/1993 | US5194430 Heterocyclic-nmda antagonists |
| 03/16/1993 | CA1314655C Hydroxylamine derivatives |
| 03/16/1993 | CA1314562C Antiarthritic beta-cyclo-alkyl-beta-oxopropionitriles |
| 03/16/1993 | CA1314553C Bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
| 03/11/1993 | CA2077213A1 Bicyclic carboxylic acid derivatives |
| 03/10/1993 | EP0531219A1 Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs |
| 03/10/1993 | EP0530207A1 Imidazopyridine paf antagonists |
| 03/10/1993 | EP0525033A4 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
| 03/10/1993 | EP0525002A4 2(5h)-furanones substituted in the 3 position, as ca?2+ channel antagonists and anti-inflammatory agents |
| 03/10/1993 | EP0524979A4 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents |
| 03/10/1993 | EP0312581B1 Pharmaceutical sustained release matrix and process |
| 03/10/1993 | CN1069732A 1,7-Condensed 2-(piperazinealkyl)-indole derivatives and process for preparing same and intermediate and pharmaceutical containing same |
| 03/10/1993 | CA2077732A1 Heterocyclic derivatives |
| 03/10/1993 | CA2074419A1 1,4-dihydropyridines with paf-antagonistic activity |
| 03/09/1993 | US5192771 (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents |
| 03/09/1993 | US5192753 Anti-rheumatoid arthritic drugs in the treatment of dementia |
| 03/09/1993 | US5192746 Cyclic cell adhesion modulation compounds |
| 03/09/1993 | CA1314290C Hydroxamic acids of 7-oxabicycloheptane substituted ethers |
| 03/09/1993 | CA1314218C Remote administration of hyaluronic acid to mammals |
| 03/07/1993 | CA2077577A1 Condensed 5-membered heterocyclic compounds, processes for preparing them and pharmaceutical preparations containing these compounds |
| 03/06/1993 | WO1993004679A1 Macrocyclic immunomodulators |
| 03/06/1993 | CA2103453A1 Macrocyclic immunomodulators |
| 03/04/1993 | WO1993004056A1 New leukotriene-b4 antagonists, methods of preparing them and their use as drugs |
| 03/04/1993 | WO1993004040A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 03/04/1993 | WO1993003746A1 Preparation of medicaments containing the peptidoglycan monomer or its derivatives |
| 03/04/1993 | WO1993003730A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | WO1993000330A3 Azanorbornane derivatives |
| 03/04/1993 | WO1992020650A3 Phosphite-borane compounds, and method of making and using the same |
| 03/04/1993 | WO1992018160A3 Method for inhibiting adhesion of white blood cells to endothelial cells |
| 03/04/1993 | DE4128690A1 Bicyclische sulfone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel Bicyclic sulfones, process for their production and containing the same drug |
| 03/04/1993 | CA2115994A1 Protein kinase c inhibition and novel compound balanol |
| 03/04/1993 | CA2115270A1 The use of the peptidoglycan monomer (pgm), its n-acyl derivatives, and its metal complexes in the preparation of medicaments for the correction of the immunosuppressive and hepatosuppressive states of the organism |
| 03/04/1993 | CA2114951A1 New leukotriene-b antagonists, methods of preparing them and their use as drugs |
| 03/04/1993 | CA2112397A1 Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 03/03/1993 | EP0529749A1 Leukotriene-B4-antagonists, method for their preparation, and their use as medicaments |
| 03/03/1993 | EP0529568A1 Novel orally-active elastase inhibitors |
| 03/03/1993 | EP0529499A1 Compositions for topical administration to the nose or the eyes containing bradykinin antagonists |
| 03/03/1993 | EP0529452A2 1,7-Condensed 2-(piperazinoalkyl)indol derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 03/03/1993 | EP0529450A1 Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors |
| 03/03/1993 | EP0529123A1 Pharmaceutical preparation for percutaneous absorption |